MYH14 and ocular melanoma: The above data on OM and the results of a preclinical investigation on cardiac S1 myosin with omecamtiv and danicamtiv are suggestive of an increase in the myosin ATPase rate even at diastolic Ca2+ levels by direct myosin activators [11,20].